PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 66 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $436,000 | -24.0% | 70,378 | -0.6% | 0.20% | -29.2% |
| Q4 2021 | $574,000 | -78.3% | 70,803 | -60.1% | 0.28% | -76.1% |
| Q3 2021 | $2,646,000 | -39.5% | 177,589 | -49.1% | 1.19% | -26.9% |
| Q2 2021 | $4,376,000 | +3608.5% | 348,703 | +115.2% | 1.63% | +2130.1% |
| Q1 2020 | $118,000 | – | 162,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
| Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
| Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
| INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
| REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
| Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
| tru Independence LLC | 500 | $0 | 0.00% |
| Renaissance Technologies | 120,269 | $319,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
| VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |